Eksempler på bruk av Efficacy endpoints på Engelsk og deres oversettelse til Norsk
{-}
-
Colloquial
-
Ecclesiastic
-
Ecclesiastic
-
Computer
placebo-controlled study evaluating efficacy endpoints at Week 6 and Week 52.
secondary composite efficacy endpoints, and the results of all the individual components of the composite endpoints are shown in Figure 1.
Secondary efficacy endpoints included time to disease progression(TTP)
Other efficacy endpoints include the cumulative MCyR rate,
Data collected in the post-marketing phase will also be examined to determine if a suitable Naglazyme maintenance dose can be recommended relative to the efficacy endpoints used in the clinical studies.
Secondary efficacy endpoints were overall survival(OS),
the key secondary(CGI-I and PGI-I responder rates) efficacy endpoints in a double-blind placebo-controlled trial including a total of 539 patients with early Parkinson's disease.
major secondary efficacy endpoints.
As secondary efficacy endpoint overall survival(Table 6) was assessed.
The study met its primary efficacy endpoint for both pasireotide intramuscular use doses.
Twelve-month persistent infection was evaluated as additional efficacy endpoint.
Serum anti- HBs trough levels of 100 IU/l and higher(primary efficacy endpoint) were maintained for all patients during the 18 to 24 week trial period.
The key efficacy endpoint was the sponsor-defined clinical outcome at test-of-cure(TOC),
VIEW2 Eylea demonstrated clinically meaningful changes from baseline in pre-specified secondary efficacy endpoint National Eye Institute Visual Function Questionnaire(NEI VFQ-25)
the most important secondary efficacy endpoint, was achieved in 51.0%(week 4) and 44.2%(week 12)
confirmatory secondary efficacy endpoint(proportion of patients who gained 15 letters in BCVA)
Efficacy endpoints used in the clinical studies.
Secondary efficacy endpoints were pCR rate in the breast(ypT0/is),
Efficacy endpoints for the docetaxel arms versus the control arm are summarized in the following table.
time to event related efficacy endpoints showed consistent results for subcutaneous